Protocol for clinical management of skin lesions in patients with monkeypox virus infection
DOI:
https://doi.org/10.56294/hl2024.37Keywords:
Protocol, clinical management, skin lesions, monkeypox, virus infectionAbstract
Introduction: monkeypox has gained relevance in global health due to its clinical and epidemiological impact. This zoonosis, caused by Orthopoxvirus, has similarities with human smallpox and can present severe complications. In Ecuador, MPOX is a public health concern, especially due to human-animal interaction and the country's tropical environment.
Objective: to describe the protocol developed by Omnihospital for the management of skin lesions associated with MPOX, in order to optimize patient care and standardize treatment in cases of this emerging disease.
Development: The main symptoms are described and include fever, malaise, headache and a phased rash (macules, papules, vesicles and crusts). Lesions are usually concentrated on the face and extremities, and may affect mucous membranes and organs such as the eyes and genitals. Complications include secondary infections of the skin lesions, treated with topical or systemic antibiotics depending on the severity. The proper use of Personal Protective Equipment (PPE) and hygiene measures is essential to prevent the spread of the virus and protect healthcare personnel.
Final considerations: the protocol seeks to provide health professionals with a practical guide for the treatment of patients with MPOX, ranging from the cleaning of lesions to the prevention of complications, thus ensuring an effective and evidence-based response
References
1. Arranz Izquierdo J, Molero García JM, Gutiérrez Pérez MI. Manejo desde atención primaria de la infección por la viruela del mono (MPOX) en humanos. Aten Primaria 2023;55:102680. https://doi.org/10.1016/j.aprim.2023.102680.
2. Vera Villamar RA, Orellana Barros MR, Orellana Tapia BA, Yunga Ortiz DI. VIRUELA SÍMICA: REVISIÓN BIBLIOGRÁFICA: Monkeypox: Bibliographic Review. Más Vita 2022;4:77-85. https://doi.org/10.47606/ACVEN/MV0113.
3. Viruela símica (mpox) s. f. https://www.who.int/es/news-room/fact-sheets/detail/mpox (accedido 12 de septiembre de 2024).
4. Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022 s. f. https://www.who.int/publications/i/item/WHO-MPX-Clinical-and-IPC-2022.1 (accedido 12 de septiembre de 2024).
5. Bertozzi S, Revelo K, Castro S. Proctitis como primera manifestación clínica de la viruela símica en un paciente con infección por el virus de la inmunodeficiencia humana en Ecuador. Piel 2023;38:516-8. https://doi.org/10.1016/j.piel.2023.03.009.
6. Álvarez Aliaga A. La viruela símica, detección precoz, diagnóstico y tratamiento. Multimed s. f.;26.
7. Eduardo Marín-Hernández, aría José Calvo-Domínguez, Yazmín Zacate-Palacios, Tania Colin-Martínez, Alma Mariana Jaimes-Velez. Monkeypox. Dermatol Rev Mex s. f.;66:523-34. https://doi.org/10.24245/dermatolrevmex.v66i5.8132.
8. Titanji BK, Tegomoh B, Nematollahi S, Konomos M, Kulkarni PA. Monkeypox: A Contemporary Review for Healthcare Professionals. Open Forum Infect Dis 2022;9:ofac310. https://doi.org/10.1093/ofid/ofac310.
9. Mazur-Melewska K. Poxviruses in Children. En: Rezaei N, editor. Poxviruses, vol. 1451, Cham: Springer Nature Switzerland; 2024, p. 205-17. https://doi.org/10.1007/978-3-031-57165-7_13.
Published
Issue
Section
License
Copyright (c) 2024 José Vergara Centeno, Oscar Caicho Caicedo, Cesar Narvaez Peñaloza, Carmen Soria Segarra, Francisco Abarca Rendón (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
